Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
Filing tables
Filing exhibits
EPIX similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the registration statements on Form S-3 (No. 333-250971 and No. 333-250967) and Form S-8 (No. 333-245143, No. 333-239541, No. 333-225056 and No. 333-210217) of ESSA Pharma Inc. of our report dated December 12, 2022, relating to the consolidated financial statements of ESSA Pharma Inc., for the years ended September 30, 2022 and 2021 which appears in the annual report on Form 10-K of ESSA Pharma Inc. dated December 12, 2022.
“DAVIDSON & COMPANY LLP”
Vancouver, Canada | Chartered Professional Accountants |
| |
December 12, 2022 | |